Seneca, Senne; Simon, Johanna; Weber, Claudia et al.
How Low Can You Go? Low Densities of Poly(ethylene glycol) Surfactants Attract Stealth ProteinsMACROMOLECULAR BIOSCIENCE. Bd. 18. H. 9. 2018
Hopprich, Anne; Reinholz, Ulrike; Gerlach, Christina et al.
How to Identify the Inpatient's Palliative Care Needs in a Hemato-Oncological Ward: Ask the Nurses!JOURNAL OF PALLIATIVE MEDICINE. Bd. 21. H. 1. 2018 S. 4-5
Muehe, Anne M.; Theruvath, Ashok J.; Lai, Lillian et al.
How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford ApproachMOLECULAR IMAGING AND BIOLOGY. Bd. 20. H. 2. 2018 S. 324-335
Zhong, Xiaoxia; Prinz, Andreas; Steger, Julia et al.
HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genesBLOOD ADVANCES. Bd. 2. H. 22. 2018 S. 3137-3148
Zepp, F.
HPV-Vaccines do not pose an increased Risk of Guillain-Barre SyndromeMONATSSCHRIFT KINDERHEILKUNDE. Bd. 166. H. 8. 2018 S. 657-657
Schepler, Hadrian; Rietz, Stephan; von Stebut, Esther et al.
Huge pedunculated tumor of the thighJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 16. H. 3. 2018 S. 365-367
Kasaj, Adrian; Willershausen, Brita; Junker, Rudiger et al.
human periodontal ligament fibroblasts stimulated by nanocrystalline hydroxyapatite paste or enamel matrix derivative. An in vitro assessment of PDL attachment, migration, and proliferation (vol 16, pg 745, 2018)CLINICAL ORAL INVESTIGATIONS. Bd. 22. H. 8. 2018 S. 2963-2963
Simon, Johanna; Wolf, Thomas; Klein, Katja et al.
Hydrophilicity Regulates the Stealth Properties of Polyphosphoester-Coated NanocarriersANGEWANDTE CHEMIE-INTERNATIONAL EDITION. Bd. 57. H. 19. 2018 S. 5548-5553
Holmer, Amadeus; Marotz, Joerg; Wahl, Philip et al.
Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parametersBIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK. Bd. 63. H. 5. 2018 S. 547-556
Gopal, Ajay K.; Schuster, Stephen J.; Fowler, Nathan H. et al.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 23. 2018 S. 2405-+